Kadant KAI holder files Form 144 to sell 1,435 common shares

Rhea-AI Filing Summary

Kadant Inc. (KAI) had a holder file a Form 144 to potentially sell 1,435 shares of its common stock on the NYSE, with an aggregate market value of $405,019.23.

The planned sale would be executed through Wells Fargo Clearing Services and is targeted around November 25, 2025. The filing notes that 11,778,135 shares of Kadant common stock were outstanding, providing context for the relative size of the proposed sale. The shares were acquired through multiple restricted stock vesting events between June 2022 and September 2023.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Wells Fargo Clearing Services 1 North Jefferson Avenue St. Louis MO 63103	1435	405019.23	11778135	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	06/01/2022	Restricted Stock Vesting	Issuer			471	06/01/2022	N/A
common	10/01/2022	Restricted Stock Vesting	Issuer			235	10/01/2022	N/A
common	12/31/2022	Restricted Stock Vesting	Issuer			235	12/31/2022	N/A
common	06/01/2023	Restricted Stock Vesting	Issuer			434	06/01/2023	N/A
common	09/30/2023	Restricted Stock Vesting	Issuer			60	09/30/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Kadant (KAI) Form 144 filing disclose?

The Form 144 filing for Kadant Inc. (KAI) discloses a planned sale of 1,435 shares of Kadant common stock on the NYSE, with an aggregate market value of $405,019.23.

How many Kadant (KAI) shares are planned to be sold and through which broker?

The filing indicates a planned sale of 1,435 common shares of Kadant Inc. through Wells Fargo Clearing Services, to be executed on the NYSE.

When is the approximate sale date for the Kadant (KAI) shares in this Form 144?

The Form 144 lists an approximate sale date of November 25, 2025 for the 1,435 Kadant common shares.

What is the aggregate market value of the Kadant (KAI) shares covered by this Form 144?

The 1,435 Kadant common shares covered by this Form 144 have an aggregate market value of $405,019.23.

How many Kadant (KAI) shares were outstanding according to this Form 144?

The filing reports that 11,778,135 shares of Kadant common stock were outstanding, giving context to the size of the planned 1,435-share sale.

How were the Kadant (KAI) shares in this Form 144 originally acquired?

The shares were acquired through several restricted stock vesting transactions from the issuer between June 1, 2022 and September 30, 2023, in amounts ranging from 60 to 471 shares per vesting event.

What is the purpose of a Form 144 in relation to Kadant (KAI)?

Form 144 is a notice of a proposed sale of restricted or control securities. In this case, it gives notice of a planned sale of Kadant common shares that were previously acquired through restricted stock vesting.